NanoViricides, Inc

(NYSE MKT:NNVC)

Latest On NanoViricides, Inc (NNVC):

Date/Time Type Description Signal Details
2023-05-06 05:34 ESTNewsNanoviricides files for $150M mixed shelf offeringN/A
2023-04-25 20:07 ESTNewsNanoViricides looking at other uses for COVID drug candidate NV-387N/A
2022-11-15 22:49 ESTNewsNanoViricides moves closer to putting COVID drug in human trials; FQ1 net loss narrowsN/A
2022-09-20 02:30 ESTNewsNanoViricides reports monkeypox antiviral could reach clinical status rapidlyN/A
2022-08-04 14:36 ESTNewsNanoViricides stock skyrockets 50% on start of drug development program for monkeypoxN/A
2022-05-16 16:24 ESTNewsNanoViricides stock rises on starting drug screening program to fight severe hepatitis in kidsN/A
2022-04-25 08:13 ESTNewsNanoViricides provides update on potential COVID drug NV-CoV-2N/A
2022-02-15 08:02 ESTNewsNanoViricides GAAP EPS of -$0.17N/A
2021-10-11 15:19 ESTNewsNanoViricides' NV-CoV-2 shows broad-spectrum Pan-Coronavirus activityN/A
2021-10-05 11:25 ESTNewsNanoViricides provides update on its Pan-COVID-19 drug development programN/A
2021-09-22 01:53 ESTNewsNanoViricides surges 60% on COVID remdesivir encapsulation dataN/A
2021-03-09 21:00 ESTNewsNanoViricides reports strong pre-clinical data for COVID-19 drugsN/A
2021-03-04 06:22 ESTNewsFUBO, RKT, TRXC and SOS among midday moversN/A
2021-03-02 16:48 ESTNewsNanoViricides shares rally 29% on effectiveness of COVID-19 drug candidates in cell culture studiesN/A
2021-02-18 12:03 ESTFinancialsCompany financials have been released.Neutral
2021-02-17 07:05 ESTNewsNanoViricides reports FQ2 resultsN/A
2021-02-10 15:55 ESTNewsNanoViricides’ COVID-19 candidate well tolerated in animal studiesN/A
2020-11-26 20:59 ESTFinancialsCompany financials have been released.Neutral
2020-11-19 12:52 ESTFinancialsCompany financials have been released.Neutral
2020-11-18 12:44 ESTEarnings EstimateAn EPS average of -$0.45 is estimated for the 2022 year.Sell
2020-11-18 12:44 ESTEarnings EstimateAn EPS average of -$1.50 is estimated for the 2021 year.Sell
2020-11-17 15:30 ESTNewsNanoViricides reports FQ1 resultsN/A
2020-11-08 00:20 ESTFinancialsCompany financials have been released.Neutral
2020-11-07 16:37 ESTFinancialsCompany financials have been released.Neutral
2020-11-02 08:22 ESTFinancialsCompany financials have been released.Neutral
2020-10-30 14:01 ESTAnalyst RatingThe Analyst Target Price has increased from $0.6 to $14.5.Buy
2020-09-26 13:33 ESTFinancialsCompany financials have been released.Neutral
2020-09-17 05:39 ESTFinancialsCompany financials have been released.Neutral
2020-09-17 02:22 ESTNewsNanoViricides picks COVID-19 drug candidate, shares up 7%N/A
2020-09-05 09:54 ESTNewsNanoViricides closing in on COVID-19 drugN/A
2020-09-02 21:36 ESTNewsNanoViricides to provide COVID-19 drug update on September 3N/A
2020-08-31 05:44 ESTFinancialsCompany financials have been released.Neutral
2020-08-14 09:36 ESTFinancialsCompany financials have been released.Neutral
2020-08-06 13:22 ESTFinancialsCompany financials have been released.Neutral
2020-07-31 01:49 ESTFinancialsCompany financials have been released.Neutral
2020-07-30 05:18 ESTFinancialsCompany financials have been released.Neutral
2020-07-27 13:14 ESTFinancialsCompany financials have been released.Neutral
2020-07-23 17:53 ESTFinancialsCompany financials have been released.Neutral
2020-07-09 18:08 ESTNewsNanoviricides commences public offering of common stockN/A
2020-07-09 18:08 ESTNewsNanoViricides prices stock offering at $7.30N/A
2020-07-09 09:29 ESTFinancialsCompany financials have been released.Neutral
2020-07-08 16:55 ESTNewsNanoviricides +54% on advancement of SARS-CoV-2 therapeutics programN/A
2020-07-01 17:17 ESTFinancialsCompany financials have been released.Neutral
2020-07-01 10:34 ESTNewsNanoViricides added to Russell Microcap indexN/A
2020-06-26 09:29 ESTFinancialsCompany financials have been released.Neutral
2020-06-24 05:18 ESTFinancialsCompany financials have been released.Neutral
2020-06-23 07:47 ESTNewsNanoViricides reports Q3 resultsN/A
2020-06-23 07:47 ESTNewsNanoViricides working on COVID-19 drug, will seek government backing if data positiveN/A
2020-06-14 05:12 ESTFinancialsCompany financials have been released.Neutral
2020-06-12 05:34 ESTFinancialsCompany financials have been released.Neutral

About NanoViricides, Inc (NNVC):

NanoViricides, Inc., a nano-biopharmaceutical company, discovers, develops, and commercializes drugs for the treatment of viral infections. Its products pipeline includes HerpeCide Dermal Topical and Eye Drops for the treatment of shingles, PHN, chickenpox, herpes, recurrent herpes labialis, genital herpes, and ocular herpes keratitis; and HerpeCide IntraOcular Injection for viral acute retinal necrosis. The company also develops FluCide Broad-Spectrum Anti-Influenza nanoviricide, which is injectable for hospitalized patients and oral for outpatients; Nanoviricide eye drops for viral diseases of the external eye; DengueCide for treatment of all types of Dengue viruses; and HIVCide that is an escape-resistant anti-HIV nanoviricide. In addition, it is also involved in research and development of other nanoviricides drug projects for treatment of different viruses and indications; and HerpeCide program expansion drug projects for different herpes viruses for different indications. NanoViricides, Inc. was founded in 2005 and is based in Shelton, Connecticut.

NNVC Quotes by TradingView

See Advanced Chart

General

  • Name NanoViricides, Inc
  • Symbol NNVC
  • Type Common Stock
  • Exchange NYSE MKT
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryBiotechnology
  • Full Time Employees 17
  • Last Split Factor1:20
  • Last Split Date2019-09-24
  • Fiscal Year EndJune
  • IPO Date2005-10-26
  • Gic SectorHealth Care
  • Gic GroupPharmaceuticals, Biotechnology & Life Sciences
  • Gic IndustryBiotechnology
  • Gic SubIndustryBiotechnology
  • Web URLhttp://www.nanoviricides.com
View More

Valuation

  • Price/Book (Most Recent Quarter) 2
View More

Financials

  • Most Recent Quarter 2020-12-31
  • Current Year EPS Estimate -$1.50
  • Next Year EPS Estimate -$0.45
  • Return on Assets -17%
  • Return on Equity -82%
  • Earnings Per Share -$2.40
  • Revenue Per Share $0
  • Quarterly Earnings Growth 0%
View More

Highlights

  • Market Capitalization 53.39 million
  • EBITDA -7963771
  • Analyst Target Price $14.5
  • Book Value Per Share $2.60
View More

Share Statistics

  • Shares Outstanding 10.68 million
  • Shares Float 9.55 million
  • % Held by Insiders 1049%
  • % Held by Institutions 30.73%
  • Shares Short 632964
  • Shares Short Prior Month 641648
  • Short Ratio 1.58
  • Short % of Float 6%
  • Short % of Shares Outstanding 6%
View More

Technicals

  • Beta 0.81
  • 52 Week High $12.2
  • 52 Week Low $2.85
  • 50 Day Moving Average 4.87
  • 200 Day Moving Average 4.03
View More

Dividends

  • Dividend Date 2019-09-24
  • ExDividend Date N/A
  • Dividend Yield 0%
View More

NanoViricides, Inc (NNVC) Dividend Calendar:

NNVC's last dividend payment was made to shareholders on September 24, 2019.

Ex-Dividend Date Payment Date Record Date Declared Date Amount

NanoViricides, Inc (NNVC) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-12-312021-02-23$N/A-$0.22
2020-09-302020-12-31$N/A-$0.22
2020-06-302020-09-30$N/A-$0.22
2020-03-312020-06-30$N/A-$0.23
2019-12-312020-03-31$N/A-$1.24
2019-09-302019-12-31$N/A-$0.50
2019-06-302019-09-30$N/A-$0.41-$0.8049.25%
2019-03-312019-05-15$N/A-$0.60-$0.600%
2018-12-312019-02-14$N/A-$0.60-$0.600%
2018-09-302018-10-12$N/A-$0.53
2018-06-302018-08-29$N/A-$0.48
2018-03-312018-05-21$N/A-$0.66
2017-12-312018-02-20$N/A-$0.88
2017-09-302017-11-14$N/A-$0.63
2017-06-302017-09-28$N/A-$0.81
2017-03-312017-05-15$N/A-$1.03
2016-12-312017-02-14$N/A-$0.53
2016-09-302016-11-14$N/A-$1.05
2016-06-302016-09-16$N/A-$0.57
2016-03-312016-06-01$N/A-$1.73
2015-12-312016-02-10$N/A-$0.96
2015-09-302015-12-02$N/A-$0.46
2015-06-302015-09-02$N/A-$0.44
2015-03-312015-06-03$N/A-$0.32
2014-12-312015-02-24$N/A-$0.60-$1.0040%
2014-09-302014-11-17$N/A-$0.08-$1.0092%
2014-06-302014-09-29$N/A-$2.40-$1.00-140%
2014-03-312014-05-15$N/A-$0.20-$0.8075%
2013-12-312014-02-26$N/A-$0.68
2013-09-302013-11-27$N/A-$2.63
2013-06-302013-08-28$N/A-$3.33
2013-03-312013-05-29$N/A-$1.58
2012-12-312013-02-27$N/A-$0.54
2012-09-302012-11-28$N/A-$0.81
2012-06-302012-08-29$N/A-$0.77
2012-03-312012-05-30$N/A-$0.94
2011-12-312012-02-29$N/A-$0.66
2011-09-302011-10-13$N/A-$0.55-$0.7021.14%
2011-03-312011-05-20$N/A-$1.27-$0.70-81.61%
2010-12-312010-12-31$N/A-$0.80
2010-09-302010-09-30$N/A-$0.57
2010-06-302010-06-30-$0.36
2010-03-312010-03-31-$1.29
2009-12-312009-12-31-$0.51
2009-09-302009-09-30-$0.41
2009-06-302009-06-30-$0.37
2009-03-312009-03-31-$0.45
2008-12-312008-12-31-$0.36
2008-09-302008-09-30-$0.43
2008-03-312008-03-31-$0.46
2007-12-312007-12-31-$0.22
2007-09-302007-09-30-$0.35
2007-03-312007-03-31-$0.57
2006-12-312006-12-31-$0.43
2006-09-302006-09-30-$0.47

NanoViricides, Inc (NNVC) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date
Research Development
Income Before Tax
Selling General Administrative
Gross Profit
Ebit
Operating Income
Income Tax Expense
Total Revenue
Cost of Revenue
Total Other Income Expense Net
Net Income From Continuing Operations
Net Income Applicable to Common Shares
Cash Flow:
Date
Investments
Change to Liabilities
Total Cash Flow from Investing Activities
Net Borrowings
Total Cash Flow from Financial Activities
Change to Operating Activities
Change in Cash
Total Cash from Operating Activities
Depreciation
Other Cash Flow from Investing Activities
Change to Inventory
Change to Account Receivables
Other Cash Flow from Financing Activities
Change to Net Income
Capital Expenditures
Balance Sheet:
Date
Total Liabailities
Total Stockholder Equity
Other Current Liabilities
Total Assets
Common Stock
Other Current Assets
Retained Earnings
Other Liabilities
Other Assets
Cash
Total Current Liabilities
Other Stockholder Equity
Property, Plant & Equipment
Total Current Assets
Long Term Investments
Net Tangible Assets
Short Term Investments
Long Term Debt
Inventory
Accounts Payable

NanoViricides, Inc (NNVC) Chart:

NanoViricides, Inc (NNVC) News:

Below you will find a list of latest news for NanoViricides, Inc (NNVC) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

NanoViricides, Inc (NNVC) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent
2024-05-172.50.05CALL0 760FALSE00
2024-05-1750CALL0 00FALSE00
2024-05-177.50CALL0 00FALSE00
2024-05-172.50PUT0 0426.75TRUE00
2024-05-1750PUT0 00TRUE00
2024-05-177.50PUT0 0503.1TRUE00
2024-06-212.50.15CALL0 1750FALSE00
2024-06-2150.05CALL0 180FALSE00
2024-06-217.50CALL0 00FALSE00
2024-06-212.50PUT0 0560.82TRUE00
2024-06-2150PUT0 0240.61TRUE00
2024-06-217.50PUT0 00TRUE00
2024-09-202.50.2CALL0 91124.39FALSE00
2024-09-2050.04CALL0 70FALSE00
2024-09-207.50.17CALL0 10FALSE00
2024-09-202.50PUT0 0250.51TRUE00
2024-09-2053.9PUT0 2169.52TRUE00
2024-09-207.50PUT0 0204.1TRUE00

Latest NNVC Trades:

Date Shares Price
Jun 13, 2022 6:08 PM EST100$1.935

NanoViricides, Inc (NNVC) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-06-2210-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1379006/000110465920075651/0001104659-20-075651-index.htm
2017-03-15UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1379006/000000000017008636/0000000000-17-008636-index.htm
2019-12-09UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1379006/000000000019016217/0000000000-19-016217-index.htm
2020-03-26UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1379006/000000000020002654/0000000000-20-002654-index.htm
2020-01-27SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1379006/000090266420000482/0000902664-20-000482-index.htm
2019-10-16PRE 14AOther preliminary proxy statementshttps://www.sec.gov/Archives/edgar/data/1379006/000110465919054247/0001104659-19-054247-index.htm
2019-10-28DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1379006/000110465919056946/0001104659-19-056946-index.htm
2019-11-06RWRegistration Withdrawal Requesthttps://www.sec.gov/Archives/edgar/data/1379006/000110465919060199/0001104659-19-060199-index.htm
2019-11-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1379006/000110465919060203/0001104659-19-060203-index.htm
2019-11-14NT 10-QNotification of inability to timely file Form 10-Q or 10-QSBhttps://www.sec.gov/Archives/edgar/data/1379006/000110465919064036/0001104659-19-064036-index.htm
2019-11-1510-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1379006/000110465919064800/0001104659-19-064800-index.htm
2019-11-29S-1General form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1379006/000110465919068364/0001104659-19-068364-index.htm
2019-12-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1379006/000110465919072646/0001104659-19-072646-index.htm
2019-12-17S-1/AGeneral form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1379006/000110465919073165/0001104659-19-073165-index.htm
2019-12-17FWPFiling under Securities Act Rules 163/433 of free writing prospectuseshttps://www.sec.gov/Archives/edgar/data/1379006/000110465919073169/0001104659-19-073169-index.htm
2019-12-198-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1379006/000110465919074405/0001104659-19-074405-index.htm
2019-12-23S-1/AGeneral form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1379006/000110465919075427/0001104659-19-075427-index.htm
2020-01-028-K/ACurrent reporthttps://www.sec.gov/Archives/edgar/data/1379006/000110465920000201/0001104659-20-000201-index.htm
2020-01-07S-1/AGeneral form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1379006/000110465920001737/0001104659-20-001737-index.htm
2020-01-08S-1/AGeneral form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1379006/000110465920002298/0001104659-20-002298-index.htm
2020-01-08CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1379006/000110465920002319/0001104659-20-002319-index.htm
2020-01-09CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1379006/000110465920002474/0001104659-20-002474-index.htm
2020-01-24424B1Prospectus [Rule 424(b)(1)]https://www.sec.gov/Archives/edgar/data/1379006/000110465920006423/0001104659-20-006423-index.htm
2020-01-278-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1379006/000110465920007211/0001104659-20-007211-index.htm
2020-01-288-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1379006/000110465920007313/0001104659-20-007313-index.htm
2020-02-05PRE 14AOther preliminary proxy statementshttps://www.sec.gov/Archives/edgar/data/1379006/000110465920011241/0001104659-20-011241-index.htm
2020-02-118-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1379006/000110465920016291/0001104659-20-016291-index.htm
2020-02-1410-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1379006/000110465920021930/0001104659-20-021930-index.htm
2020-02-19DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1379006/000110465920022509/0001104659-20-022509-index.htm
2020-03-208-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1379006/000110465920036792/0001104659-20-036792-index.htm
2020-03-24S-3Registration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1379006/000110465920037812/0001104659-20-037812-index.htm
2020-03-31CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1379006/000110465920040898/0001104659-20-040898-index.htm
2020-05-013Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1379006/000110465920055415/0001104659-20-055415-index.htm
2020-05-148-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1379006/000110465920061689/0001104659-20-061689-index.htm
2020-05-198-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1379006/000110465920063847/0001104659-20-063847-index.htm
2020-05-22424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1379006/000110465920064991/0001104659-20-064991-index.htm
2020-05-228-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1379006/000110465920065358/0001104659-20-065358-index.htm
2020-05-29SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1379006/000110465920067429/0001104659-20-067429-index.htm
2020-06-048-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1379006/000110465920069859/0001104659-20-069859-index.htm
2020-06-2210-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1379006/000110465920075651/0001104659-20-075651-index.htm
2020-07-09424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1379006/000110465920082204/0001104659-20-082204-index.htm
2020-07-09424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1379006/000110465920082422/0001104659-20-082422-index.htm
2020-07-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1379006/000110465920083121/0001104659-20-083121-index.htm
2020-07-31424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1379006/000110465920089188/0001104659-20-089188-index.htm
2020-08-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1379006/000110465920089704/0001104659-20-089704-index.htm
2020-09-048-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1379006/000110465920102620/0001104659-20-102620-index.htm
2020-09-28NT 10-KNotification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405https://www.sec.gov/Archives/edgar/data/1379006/000110465920109325/0001104659-20-109325-index.htm
2020-10-1310-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1379006/000110465920114577/0001104659-20-114577-index.htm
2020-10-26DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1379006/000110465920118177/0001104659-20-118177-index.htm
2015-09-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1379006/000114036115035878/0001140361-15-035878-index.htm
2015-09-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1379006/000114036115035881/0001140361-15-035881-index.htm
2018-05-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1379006/000114036118021800/0001140361-18-021800-index.htm
2015-05-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1379006/000114420415032895/0001144204-15-032895-index.htm
2015-06-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1379006/000114420415037879/0001144204-15-037879-index.htm
2015-06-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1379006/000114420415039151/0001144204-15-039151-index.htm
2015-07-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1379006/000114420415042096/0001144204-15-042096-index.htm
2015-07-248-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1379006/000114420415044157/0001144204-15-044157-index.htm
2015-08-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1379006/000114420415051838/0001144204-15-051838-index.htm
2015-08-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1379006/000114420415052403/0001144204-15-052403-index.htm
2015-09-1410-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1379006/000114420415054864/0001144204-15-054864-index.htm
2015-09-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1379006/000114420415055102/0001144204-15-055102-index.htm
2015-10-234Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1379006/000114420415060613/0001144204-15-060613-index.htm
2015-11-0910-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1379006/000114420415063679/0001144204-15-063679-index.htm
2015-11-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1379006/000114420415066271/0001144204-15-066271-index.htm
2015-12-08DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1379006/000114420415069795/0001144204-15-069795-index.htm
2016-01-298-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1379006/000114420416077921/0001144204-16-077921-index.htm
2016-02-0910-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1379006/000114420416079966/0001144204-16-079966-index.htm
2016-02-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1379006/000114420416082885/0001144204-16-082885-index.htm
2016-02-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1379006/000114420416084125/0001144204-16-084125-index.htm
2016-04-07POS AMPost-Effective amendments for registration statementhttps://www.sec.gov/Archives/edgar/data/1379006/000114420416093294/0001144204-16-093294-index.htm
2016-05-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1379006/000114420416098303/0001144204-16-098303-index.htm
2016-05-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1379006/000114420416099213/0001144204-16-099213-index.htm
2016-05-1010-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1379006/000114420416100445/0001144204-16-100445-index.htm
2016-05-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1379006/000114420416103281/0001144204-16-103281-index.htm
2016-05-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1379006/000114420416104385/0001144204-16-104385-index.htm
2016-09-1610-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1379006/000114420416124276/0001144204-16-124276-index.htm
2016-10-28DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1379006/000114420416130330/0001144204-16-130330-index.htm
2016-11-1410-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1379006/000114420416134199/0001144204-16-134199-index.htm
2016-12-158-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1379006/000114420416139764/0001144204-16-139764-index.htm
2017-02-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1379006/000114420417005838/0001144204-17-005838-index.htm
2017-02-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1379006/000114420417008029/0001144204-17-008029-index.htm
2017-02-1410-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1379006/000114420417009000/0001144204-17-009000-index.htm
2017-03-01S-3Registration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1379006/000114420417011857/0001144204-17-011857-index.htm
2017-04-18S-3/ARegistration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1379006/000114420417020912/0001144204-17-020912-index.htm
2017-04-18CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1379006/000114420417020914/0001144204-17-020914-index.htm
2017-04-20CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1379006/000114420417021300/0001144204-17-021300-index.htm
2017-05-1510-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1379006/000114420417027501/0001144204-17-027501-index.htm
2017-09-2810-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1379006/000114420417050412/0001144204-17-050412-index.htm
2017-10-27DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1379006/000114420417054403/0001144204-17-054403-index.htm
2017-11-08DEFR14ARevised definitive proxy soliciting materialshttps://www.sec.gov/Archives/edgar/data/1379006/000114420417057336/0001144204-17-057336-index.htm
2017-11-1410-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1379006/000114420417059130/0001144204-17-059130-index.htm
2017-11-22424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1379006/000114420417060674/0001144204-17-060674-index.htm
2017-12-158-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1379006/000114420417063872/0001144204-17-063872-index.htm
2018-02-14NT 10-QNotification of inability to timely file Form 10-Q or 10-QSBhttps://www.sec.gov/Archives/edgar/data/1379006/000114420418009046/0001144204-18-009046-index.htm
2018-02-2010-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1379006/000114420418009768/0001144204-18-009768-index.htm
2018-05-048-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1379006/000114420418025443/0001144204-18-025443-index.htm
2018-05-15NT 10-QNotification of inability to timely file Form 10-Q or 10-QSBhttps://www.sec.gov/Archives/edgar/data/1379006/000114420418028923/0001144204-18-028923-index.htm
2018-05-2110-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1379006/000114420418030083/0001144204-18-030083-index.htm
2018-07-118-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1379006/000114420418037894/0001144204-18-037894-index.htm
2018-07-198-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1379006/000114420418038907/0001144204-18-038907-index.htm
2018-07-238-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1379006/000114420418039366/0001144204-18-039366-index.htm
2018-09-128-K/ACurrent reporthttps://www.sec.gov/Archives/edgar/data/1379006/000114420418049074/0001144204-18-049074-index.htm
2018-09-28NT 10-KNotification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405https://www.sec.gov/Archives/edgar/data/1379006/000114420418051597/0001144204-18-051597-index.htm
2018-10-1210-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1379006/000114420418053665/0001144204-18-053665-index.htm
2018-10-19DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1379006/000114420418054566/0001144204-18-054566-index.htm
2018-10-318-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1379006/000114420418056517/0001144204-18-056517-index.htm
2018-11-1410-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1379006/000114420418059983/0001144204-18-059983-index.htm
2018-12-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1379006/000114420418063617/0001144204-18-063617-index.htm
2019-02-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1379006/000114420419004468/0001144204-19-004468-index.htm
2019-02-1410-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1379006/000114420419008138/0001144204-19-008138-index.htm
2019-03-01424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1379006/000114420419011400/0001144204-19-011400-index.htm
2019-03-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1379006/000114420419011452/0001144204-19-011452-index.htm
2019-03-08DNotice of Exempt Offering of Securitieshttps://www.sec.gov/Archives/edgar/data/1379006/000114420419012971/0001144204-19-012971-index.htm
2019-05-1510-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1379006/000114420419026612/0001144204-19-026612-index.htm
2019-06-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1379006/000114420419030343/0001144204-19-030343-index.htm
2019-08-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1379006/000114420419037222/0001144204-19-037222-index.htm
2019-08-203Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1379006/000114420419040854/0001144204-19-040854-index.htm
2019-08-2310-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1379006/000114420419041547/0001144204-19-041547-index.htm
2019-09-268-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1379006/000114420419045967/0001144204-19-045967-index.htm
2019-09-27S-1General form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1379006/000114420419046313/0001144204-19-046313-index.htm
2018-10-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1379006/000121465918006488/0001214659-18-006488-index.htm
2018-10-12SC 13DGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1379006/000121465918006490/0001214659-18-006490-index.htm
2020-07-20SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1379006/000138713120006537/0001387131-20-006537-index.htm
2020-01-24SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1379006/000153561020000061/0001535610-20-000061-index.htm
2016-04-14EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1379006/999999999516004208/9999999995-16-004208-index.htm
2017-04-25EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1379006/999999999517000938/9999999995-17-000938-index.htm
2020-01-09EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1379006/999999999520000048/9999999995-20-000048-index.htm
2020-04-02EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1379006/999999999520000674/9999999995-20-000674-index.htm

NanoViricides, Inc (NNVC) Insider Transactions:

Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of NanoViricides, Inc (NNVC). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 1049%
Institutional Ownership: 3073%

Transaction Date Insider Name Insider Title Type Shares Number Shares Price Total Transaction Shares Held After Transaction Link
2015-09-11MILTON BONIUKDirectorBuy50,000.001.0251,000.00100,000.00https://www.sec.gov/Archives/edgar/data/1379006/000114420415055102/0001144204-15-055102-index.htm
2015-10-15MILTON BONIUKDirectorBuy2,200.001.302,860.00102,200.00https://www.sec.gov/Archives/edgar/data/1379006/000114420415060613/0001144204-15-060613-index.htm
2015-10-19MILTON BONIUKDirectorBuy2,958.001.303,845.40105,158.00https://www.sec.gov/Archives/edgar/data/1379006/000114420415060613/0001144204-15-060613-index.htm
2017-02-21MILTON BONIUK10% Share HolderBuy153,611.001,092,426.00https://www.sec.gov/Archives/edgar/data/1379006/000121465918006488/0001214659-18-006488-index.htm
2015-10-21MILTON BONIUKDirectorBuy5,202.001.306,762.60110,360.00https://www.sec.gov/Archives/edgar/data/1379006/000114420415060613/0001144204-15-060613-index.htm
2016-02-18MILTON BONIUKDirectorBuy9,000.001.7015,300.001,142,963.00https://www.sec.gov/Archives/edgar/data/1379006/000114420416084125/0001144204-16-084125-index.htm
2016-04-27MILTON BONIUKDirectorBuy25,000.001.7844,500.001,167,963.00https://www.sec.gov/Archives/edgar/data/1379006/000114420416098303/0001144204-16-098303-index.htm
2016-04-28MILTON BONIUKDirectorBuy7,109.001.6811,943.121,175,072.00https://www.sec.gov/Archives/edgar/data/1379006/000114420416099213/0001144204-16-099213-index.htm
2016-04-29MILTON BONIUKDirectorBuy2,900.001.684,872.001,177,972.00https://www.sec.gov/Archives/edgar/data/1379006/000114420416099213/0001144204-16-099213-index.htm
2016-05-04MILTON BONIUKDirectorBuy14,991.001.6825,184.881,190,063.00https://www.sec.gov/Archives/edgar/data/1379006/000114420416103281/0001144204-16-103281-index.htm
2016-05-12MILTON BONIUKDirectorBuy25,000.001.5037,500.001,215,063.00https://www.sec.gov/Archives/edgar/data/1379006/000114420416103281/0001144204-16-103281-index.htm
2016-05-19MILTON BONIUKDirectorBuy25,000.001.5037,500.001,240,063.00https://www.sec.gov/Archives/edgar/data/1379006/000114420416104385/0001144204-16-104385-index.htm
2017-05-04MILTON BONIUK10% Share HolderBuy149,478.001,241,904.00https://www.sec.gov/Archives/edgar/data/1379006/000121465918006488/0001214659-18-006488-index.htm
2015-10-22MILTON BONIUKDirectorBuy14,640.001.3019,032.00125,000.00https://www.sec.gov/Archives/edgar/data/1379006/000114420415060613/0001144204-15-060613-index.htm
2015-09-22Eugene SeymourChief Executive OfficerBuy104,384.000.3536,534.401,287,286.00https://www.sec.gov/Archives/edgar/data/1379006/000114036115035878/0001140361-15-035878-index.htm
2017-07-11MILTON BONIUK10% Share HolderBuy120,744.001,362,648.00https://www.sec.gov/Archives/edgar/data/1379006/000121465918006488/0001214659-18-006488-index.htm
2015-05-19MILTON BONIUKDirectorBuy25,000.001.6040,000.001,480,391.00https://www.sec.gov/Archives/edgar/data/1379006/000114420415032895/0001144204-15-032895-index.htm
2015-11-11MILTON BONIUKDirectorBuy25,000.001.2030,000.00150,000.00https://www.sec.gov/Archives/edgar/data/1379006/000114420415066271/0001144204-15-066271-index.htm
2015-05-20MILTON BONIUKDirectorBuy25,000.001.6040,000.001,505,391.00https://www.sec.gov/Archives/edgar/data/1379006/000114420415032895/0001144204-15-032895-index.htm
2015-06-15MILTON BONIUKDirectorBuy7,753.002.0015,506.001,515,144.00https://www.sec.gov/Archives/edgar/data/1379006/000114420415037879/0001144204-15-037879-index.htm
2015-06-16MILTON BONIUKDirectorBuy42,247.001.9984,071.531,555,391.00https://www.sec.gov/Archives/edgar/data/1379006/000114420415037879/0001144204-15-037879-index.htm
2015-06-19MILTON BONIUKDirectorBuy6,528.001.9012,403.201,561,919.00https://www.sec.gov/Archives/edgar/data/1379006/000114420415039151/0001144204-15-039151-index.htm
2016-02-08MILTON BONIUKDirectorBuy9,000.001.4012,600.00159,000.00https://www.sec.gov/Archives/edgar/data/1379006/000114420416082885/0001144204-16-082885-index.htm
2015-06-22MILTON BONIUKDirectorBuy43,472.001.9082,596.801,605,391.00https://www.sec.gov/Archives/edgar/data/1379006/000114420415039151/0001144204-15-039151-index.htm
2015-08-13MILTON BONIUKDirectorBuy800.001.251,000.001,606,191.00https://www.sec.gov/Archives/edgar/data/1379006/000114420415051838/0001144204-15-051838-index.htm
2015-08-14MILTON BONIUKDirectorBuy8,594.001.2510,742.501,614,785.00https://www.sec.gov/Archives/edgar/data/1379006/000114420415051838/0001144204-15-051838-index.htm
2015-08-17MILTON BONIUKDirectorBuy5,244.001.256,555.001,620,029.00https://www.sec.gov/Archives/edgar/data/1379006/000114420415051838/0001144204-15-051838-index.htm
2015-08-18MILTON BONIUKDirectorBuy2,547.001.253,183.751,622,576.00https://www.sec.gov/Archives/edgar/data/1379006/000114420415051838/0001144204-15-051838-index.htm
2015-08-19MILTON BONIUKDirectorBuy300.001.25375.001,622,876.00https://www.sec.gov/Archives/edgar/data/1379006/000114420415051838/0001144204-15-051838-index.htm
2015-08-20MILTON BONIUKDirectorBuy2,662.001.253,327.501,625,538.00https://www.sec.gov/Archives/edgar/data/1379006/000114420415051838/0001144204-15-051838-index.htm
2015-08-21MILTON BONIUKDirectorBuy29,853.001.2537,316.251,655,391.00https://www.sec.gov/Archives/edgar/data/1379006/000114420415051838/0001144204-15-051838-index.htm
2016-02-10MILTON BONIUKDirectorBuy9,000.001.3612,240.00168,000.00https://www.sec.gov/Archives/edgar/data/1379006/000114420416082885/0001144204-16-082885-index.htm
2015-08-26MILTON BONIUKDirectorBuy50,000.001.0552,500.001,705,391.00https://www.sec.gov/Archives/edgar/data/1379006/000114420415052403/0001144204-15-052403-index.htm
2015-09-22Anil DiwanPresidentBuy208,771.000.3573,069.852,082,310.00https://www.sec.gov/Archives/edgar/data/1379006/000114036115035881/0001140361-15-035881-index.htm
2017-02-21MILTON BONIUK10% Share HolderBuy1,746,288.002,776,793.00https://www.sec.gov/Archives/edgar/data/1379006/000121465918006488/0001214659-18-006488-index.htm
2016-02-12MILTON BONIUKDirectorBuy141,844.001.18167,375.92309,844.00https://www.sec.gov/Archives/edgar/data/1379006/000114420416082885/0001144204-16-082885-index.htm
2015-07-08MILTON BONIUKDirectorBuy50,000.001.5879,000.0050,000.00https://www.sec.gov/Archives/edgar/data/1379006/000114420415042096/0001144204-15-042096-index.htm
2016-02-12MILTON BONIUKDirectorBuy34,043.001.1840,170.74605,474.00https://www.sec.gov/Archives/edgar/data/1379006/000114420416082885/0001144204-16-082885-index.htm
2018-05-21MILTON BONIUK10% Share HolderBuy5,500,000.006,862,648.00https://www.sec.gov/Archives/edgar/data/1379006/000121465918006488/0001214659-18-006488-index.htm
2016-02-12MILTON BONIUKDirectorBuy34,043.001.1840,170.74976,902.00https://www.sec.gov/Archives/edgar/data/1379006/000114420416082885/0001144204-16-082885-index.htm